低氧暴露与体重状态研究中的铁吸收 (LOWS-IRON)
能量限制与间歇性缺氧对肥胖症中铁吸收的影响
Declines in iron status are common in those with obesity and may be due to obesity-related chronic inflammation; however, the effects of reducing inflammation following diet-induced weight loss on iron metabolism are poorly understood. Low environmental oxygen exposure increases dietary iron absorption and availability to supply iron for erythropoiesis but has not yet been tested in the context of weight loss. This study is designed to investigate diet-induced weight loss (inflammation reduction) and overnight low oxygen exposure (erythropoiesis stimulating agent) as strategies to improve dietary iron absorption in obesity.
研究概览
详细说明
Those with obesity are at increased risk for iron deficiency, which can worsen obesity-related comorbidities and add considerably to national health-care budgets. Declines in iron status in those with obesity may be due to adiposity-related inflammation. Adipokines, such as interleukin 6, increase hepcidin, an iron regulatory hormone secreted by the liver that functions to reduce iron absorption and iron availability. Elevated hepcidin and reduced dietary iron absorption may explain why those with obesity are more susceptible to iron deficiency and more resistant to treatment with iron supplements. However, the effects of reducing inflammation on iron absorption in those with obesity are poorly understood. In addition, low environmental oxygen exposure may be an alternative to optimize iron metabolism in obesity since hypoxia stimulates the synthesis of erythropoietin, which strongly suppresses hepcidin and increases iron absorption. The proposed study aims to capitalize on the ongoing Low Oxygen and Weight Status (LOWS) randomized, double-blind, parallel-arm, controlled-feeding trial (R01DK127162; Berryman) to understand the mechanism by which obesity increases risk for iron deficiency and potential countermeasures. In LOWS, adults with obesity are randomized to 8 weeks of controlled-feeding energy restriction (-500 kcal/day) plus intermittent exposure to normobaric hypoxia (8 h/night, 15% FiO2) or normoxia (8 h/night, 21% FiO2) using a commercially available, in-home tent system. This study aims at assessing dietary iron absorption at baseline and following 8 weeks of energy restriction in normoxia or intermittent hypoxia. Results of this project will serve as a foundation to the development of interventions to prevent and treat declines in iron status in obesity.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Louisiana
-
Baton Rouge、Louisiana、美国、70808
- Pennington Biomedical Research Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Obese (BMI between 30-39.9 kg/m2)
- Born at altitudes below 2,100 meters (~7,000 feet)
- Currently residing in Baton Rouge, Louisiana or surrounding area
- Not taking any medication(s) that interfere with oxygen delivery/transport for 4 weeks prior to and throughout the entire study (e.g., includes sedatives, sleeping aids, tranquilizers and/or any medication that depresses ventilation, diuretics, alpha and beta blockers).
- Willing to refrain from smoking, vaping, chewing tobacco, and dietary supplement use throughout the entire study.
- Willing to have a hypoxic tent set-up in their home and spend 8 consecutive hours per night in the tent for 8 weeks
Exclusion Criteria:
- Living in areas that are more than 1,200 m (~4,000 feet), or have traveled to areas that are more than 1,200 m for five days or more within the last 2 months
- Cardiovascular abnormalities, gastrointestinal disorders, or any condition that interferes with oxygen delivery/transport (e.g., kidney disease, cardiovascular disease, etc.)
- Oxygen saturation < 95% while awake or oxygen saturation dips below 88% for a total of ≥ 10 min overnight in normoxic conditions
- Evidence of apnea or other sleeping disorders
- Evidence of prior high-altitude pulmonary edema (HAPE) or high-altitude cerebral edema (HACE) diagnosis
- Diagnosis or family history of sickle cell anemia/trait
- Hematocrit <42% for males, <36% for females
- Hemoglobin <13 g/dL for males, <12 g/dL for females
- Blood donation within 8 weeks of beginning the study
- Present condition of alcoholism, anabolic steroids, or other substance abuse issues
- Women who are pregnant, lactating, planning to become pregnant, or who have had an irregular menstrual cycle in the past 6 mo.
- Weight gain or loss > 10% of body weight during the past 6 months
- Adults unable to consent
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Normobaric hypoxia (NH)
8 weeks of overnight exposure (8 hrs/night) to NH conditions (~15% oxygen; achieved with nitrogen dilution, equivalent to ~8500 feet elevation) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY). |
Low oxygen exposure to mimic ~8500 feet elevation (experimental) |
|
假比较器：Normobaric normoxia (NN)
8 weeks of overnight exposure (8 hrs/night) to NN conditions (~21% oxygen; sea level) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY). |
Normal oxygen exposure to mimic sea level conditions (sham comparator). |
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in iron absorption
大体时间：7 weeks
|
Fractional iron absorption will be measured during the baseline weight maintenance phase (day -7) and at the end of the study (day 42). Change in fractional iron absorption will be calculated as: fractional iron absorption on day 42 - fractional iron absorption on day -7. |
7 weeks
|
合作者和调查者
调查人员
- 首席研究员：Camila Weschenfelder, PhD、Pennington Biomedical Research Center
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.